Revance Therapeutics Inc (NASDAQ:RVNC)

28.63
Delayed Data
As of Jan 22
 +0.24 / +0.85%
Today’s Change
11.78
Today|||52-Week Range
34.62
+1.02%
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close28.39
Today’s open27.91
Day’s range27.91 - 28.83
Volume18,989
Average volume (3 months)578,358
Market cap$1.9B
Data as of 3:59pm ET, 01/22/2021

Growth & Valuation

Earnings growth (last year)+6.93%
Earnings growth (this year)-33.44%
Earnings growth (next 5 years)--
Revenue growth (last year)-88.92%
P/E ratioNM
Price/Sales1,707.91
Price/Book6.65

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Consumer He...+0.14+0.37%
VCELVericel Corp+1.09+2.71%
----
YMABY-mAbs Therapeutics,...-0.07-0.16%
Data as of 4:00pm ET, 01/22/2021

Financials

Next reporting dateMarch 3, 2021
EPS forecast (this quarter)-$1.18
Annual revenue (last year)$413.0K
Annual profit (last year)-$159.4M
Net profit margin-38,602.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Nashville, Tennessee

Forecasts